Advertisement
Research Article

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa

  • Motasim Badri mail,

    To whom correspondence should be addressed. E-mail: motasim.badri@hiv-research.org.za

    Affiliation: Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

    X
  • Gary Maartens,

    Affiliation: Department of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa

    X
  • Sundhiya Mandalia,

    Affiliations: NPMS-HHC Coordination and Analytic Centre, Chelsea and Westminster Hospital, London, United Kingdom, Department of Medicine, Imperial College, Chelsea and Westminster Hospital, London, United Kingdom

    X
  • Linda-Gail Bekker,

    Affiliation: Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

    X
  • John R Penrod,

    Affiliation: Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada

    X
  • Robert W Platt,

    Affiliation: Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

    X
  • Robin Wood equal contributor,

    equal contributor Contributed equally to this work with: Robin Wood, Eduard J Beck

    Affiliation: Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa

    X
  • Eduard J Beck equal contributor

    equal contributor Contributed equally to this work with: Robin Wood, Eduard J Beck

    Affiliations: NPMS-HHC Coordination and Analytic Centre, Chelsea and Westminster Hospital, London, United Kingdom, Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

    X
  • Published: December 06, 2005
  • DOI: 10.1371/journal.pmed.0030004

About the Authors

Motasim Badri, Linda-Gail Bekker, Robin Wood
Department of Medicine, Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa
Gary Maartens
Department of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa
Sundhiya Mandalia, Eduard J Beck
NPMS-HHC Coordination and Analytic Centre, Chelsea and Westminster Hospital, London, United Kingdom
Sundhiya Mandalia
Department of Medicine, Imperial College, Chelsea and Westminster Hospital, London, United Kingdom
John R Penrod
Division of Clinical Epidemiology, McGill University Health Centre, Montreal, Quebec, Canada
Robert W Platt, Eduard J Beck
Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada

Corresponding Author

Email: motasim.badri@hiv-research.org.za

Competing Interests

Study was funded by Secure the Future, Bristol-Myers Squibb, through an unrestricted educational grant.

Author Contributions

MB, GM, SM, LB, JRP, RWP, RW, and EJB contributed to the conceptualization of the study. MB, GM, SM, RW, and EJB designed the study. GM, LB, and RW enrolled patients. MB and SM performed the statistical analysis. MB wrote the first draft of the paper. All authors contributed to the writing of the final version of the manuscript.